Formulation And Evaluation of Fast Dissolving Oral Films Incorporated With Ramipril and β-Cyclodextrin Complex

Authors

  • Puttaswamy Nirmala Department of Pharmaceutics, Government College of Pharmacy, Bengaluru-560027, Karnataka, India

Abstract

Ramipril being ACE inhibitor belongs to BCS class II drug with low solubility and undergoes first-pass metabolism that leads to reduced bioavailability of 28%. The current research is aimed at formulating and evaluating ramipril fast dissolving oral films (FDOF). Solubility enhancement of ramipril was done by formation of   inclusion complex with β-cyclodextrin in 3 ratios (1:0.5, 1:1, 1:2). Based on higher drug content and dissolution values the physical mixture of ramipril with β-cyclodextrin in 1:1 ratio (IC2) was chosen for further studies. Total 12 formulations of ramipril FDOF containing IC2 prepared with various polymers and evaluated for physicochemical properties. The optimized formulation F9 shown better tensile strength (11.6 g/cm2), significant % elongation (9.8) and maximum % drug content of 99.98 %. The formulation F9 exhibited minimum disintegration time of 9 sec that is desirable for immediate onset of action and maximum drug release. The FTIR data of F9 assured the compatibility of drug and formulation excipients, found to be stable for 180 days at accelerated conditions. The study confirmed that ramipril FDOF lead to quicker onset of action and enhanced therapeutic efficiency in comparison to marketed product.

Keywords:

Ramipril, antihypertensive agent, fast dissolving oral film (FDOF), β-cyclodextrin.

DOI

https://doi.org/10.25004/IJPSDR.2020.120412

References

Parkash V, Maan S, Deepika, Yadav S, Hemlata, Jogpal V. Fast disintegrating tablets: Opportunity in drug delivery system. J Adv Pharm Technol Res. 2011; 2(4):223-35.

Chaturvedi A, Srivastava P, Yadav S, Bansal M, Garg G, Sharma PK.Fast dissolving films: A review. Curr Drug Del.2011; 8(4):373-80.

Nagaraju T, Gowthami R, Rajashekar M, Sandeep S, Mallesham M, Sathish D. Comprehensive review on oral disintegrating films. Curr Drug Deliv. 2013; 10(1):96-108.

Bala R, Khanna S, Pawar P, Arora S. Orally dissolving strips: A new approach to oral drug delivery system. Int J Pharm Investig.2013;3(2):67-76.

Rohan RV, Kumbhar SM, lade RB, Salunkhe PS, Ubale RH. Dissolution Rate Enhancement of Ramipril by Solid Dispersion Technique. Asian J Pharm Res. 2020; 10(1):08-12.

Suryawanshi VK, Gidwani B, Verma A, Dubey N and Kaur CD. Formulation and evaluation of ramipril liquisolid compact using novel carrier. Int J Pharm Sci & Res. 2019; 10(2): 917-25.

Dalmora ME, Oliveira AG.Inclusion complex of piroxicam with beta-cyclodextrin and incorporation in hexadecyl trimethyl ammonium bromide based microemulsion. Int J Pharm.1999; 184(2):157-64

Prabhu P, Malli R, Koland M, Vijaynarayana K, D′Souza U, Harish N.Formu- lation and evaluation of fast dissolving films of levocitirizine dihydrochloride.Int J Pharm Investig. 2011;1(2):99-104.

Chaturvedi S, Alim M, Agrawal VK. Solubility and Dissolution enhancement of domperidone using 2-hydroxypropyl-βcyclodextrin by kneading method. Asian J Pharm. 2017;11(3):168-75.

Joshi P, Patel H, Patel V, Panchal R. Formulation development and evaluation of mouth dissolving film of domperidone. J Pharm Bioallied Sci. 2012;4(1):S108-9.

Dua K, Pabreja K, Ramana MV, Lather V. Dissolution behavior of β-cyclodextrin molecular inclusion complexes of aceclofenac. J Pharm Bioallied Sci. 2011;3(3):417-25.

Vaishali Y, Londhe, Umalkar KB. Formulation development and evaluation of fast dissolving film of telmisartan. Ind J Pharm Sci. 2012;74(2):122-6.

Kulkarni, Parthasarathi & Dixit, Mudit & Anis, Shahnawaz & Mangla, Singh & Ajay, Kulkarni & Gunashekara, K.Formulation and evaluation of mouth dissolving film containing Rofecoxib. Int Res J Pharm. 2011; 2: 273-78.

Tomar A, Sharma K, Chauhan NS, Mittal A, Bajaj U.Formulation and evaluation of fast dissolving oral film of dicyclomine as potential route of buccal delivery. Int J Drug Dev and Res. 2012;4(2):408-17.

Sharma D. Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate for respiratory disorders. ISRN Pharm.2013:674507.

Zaid A, Ghanem M, Maqboul L, Zaid H, Mahasne A. Biowaiver Eligibility of a Lower Strength Ramipril/Hydrochlorothiazide Immediate Release Tablets Using a New Validated HPLC Analytical Method. Drug Res. 2016; 66(10): 539–546.

Mashru RC, Sutariya VB, Sankalia MG, Parikh PP. Development and evaluation of fast dissolving film of salbutamol sulphate. Drug Dev Ind Pharm. 2005;31:25–34.

Choudhary DR, Patel VA, Patel HV, Kundawala AJ. Formulation and evaluation of quick dissolving film of levocetirizine dihydrochloride. Int J Pharm and Tech. 2011; 3(1):1740–49.

Mishra R, Amin A. Formulation and characterization of rapidly dissolving films of cetirizine hydrochloride using pullulan as a film forming agent. Ind J Pharm Edu Res. 2011; 45:75–6.

Published

30-07-2020
Statistics
Abstract Display: 1217
PDF Downloads: 773
Dimension Badge

How to Cite

“Formulation And Evaluation of Fast Dissolving Oral Films Incorporated With Ramipril and β-Cyclodextrin Complex”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 12, no. 4, July 2020, pp. 390-5, https://doi.org/10.25004/IJPSDR.2020.120412.

Issue

Section

Research Article

How to Cite

“Formulation And Evaluation of Fast Dissolving Oral Films Incorporated With Ramipril and β-Cyclodextrin Complex”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 12, no. 4, July 2020, pp. 390-5, https://doi.org/10.25004/IJPSDR.2020.120412.